Analyst Upgrades – Impax Laboratories (NASDAQ:IPXL) Stock Gets Upgraded By Piper Jaffray Companies from Underweight to Neutral

ME Staff
-
0

Analyst Ratings For Impax Laboratories (NASDAQ:IPXL)

Today, Impax Laboratories (NASDAQ:IPXL) stock received an upgrade by Piper Jaffray Companies from Underweight to Neutral with a price target of $16.00.

There are 1 sell rating, 8 hold ratings, 4 buy ratings on the stock.

The current consensus rating on Impax Laboratories (NASDAQ:IPXL) is Hold (Score: 2.23) with a consensus target price of $19.69 per share, a potential 8.80% upside.

Some recent analyst ratings include

  • 7/18/2017-Piper Jaffray Companies Upgrade from a “Underweight ” rating to a ” Neutral” rating.
  • 6/23/2017-BMO Capital Markets Reiterated Rating of Hold.
  • 6/16/2017-Cantor Fitzgerald initiated coverage with a Overweight rating.
  • 6/12/2017-Janney Montgomery Scott Reiterated Rating of Neutral.
  • 3/27/2017-Guggenheim Reiterated Rating of Buy.

Recent Insider Trading Activity For Impax Laboratories (NASDAQ:IPXL)
Impax Laboratories (NASDAQ:IPXL) has insider ownership of 3.30% and institutional ownership of 83.87%.

  • On 5/31/2017 Michael Nestor, Insider, sold 1,130 with an average share price of $15.00 per share and the total transaction amounting to $16,950.00. View SEC Filing
  • On 5/17/2017 Michael Nestor, Insider, sold 857 with an average share price of $16.48 per share and the total transaction amounting to $14,123.36. View SEC Filing
  • On 5/12/2017 Michael Nestor, Insider, sold 700 with an average share price of $17.11 per share and the total transaction amounting to $11,977.00. View SEC Filing
  • On 8/15/2016 Leslie Z Benet, Director, sold 10,092 with an average share price of $22.81 per share and the total transaction amounting to $230,198.52. View SEC Filing
  • On 9/11/2015 Mark A Schlossberg, SVP, sold 7,457 with an average share price of $43.30 per share and the total transaction amounting to $322,888.10. View SEC Filing
  • On 9/10/2015 Michael Nestor, Insider, sold 5,000 with an average share price of $43.56 per share and the total transaction amounting to $217,800.00. View SEC Filing
  • On 8/31/2015 Michael Markbreiter, Director, sold 28,000 with an average share price of $41.70 per share and the total transaction amounting to $1,167,600.00. View SEC Filing

Recent Trading Activity for Impax Laboratories (NASDAQ:IPXL)
Shares of Impax Laboratories closed the previous trading session at 18.42 up +0.32 1.80% with 3,419,069 shares trading hands.